Abpro Holdings, Inc. SEC filings ABPWW

Abpro Holdings, Inc. has 253 filings in SEC EDGAR's recent list, going back to Dec 2, 2021. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 1, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report May 1, 2026 Dec 31, 2025
10-K Annual report Apr 15, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Apr 15, 2025 Dec 31, 2024
10-K/A Amended annual report Apr 1, 2024 Dec 31, 2023
10-K Annual report Mar 29, 2024 Dec 31, 2023
10-K Annual report Apr 3, 2023 Dec 31, 2022
10-K Annual report Mar 25, 2022 Dec 31, 2021

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ABPO (OTC), ABPWW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1893219
Former names
Atlantic Coastal Acquisition Corp. II (until Nov 12, 2024)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.